High-priced drug development deal for Arrowhead Pharmaceuticals takes effect

Arrowhead Pharmaceuticals has finalized its agreement with Janssen Pharmaceuticals that’s worth $250 million for Arrowhead, just to start.

The waiting period under the Hart-Scott Rodino Antitrust Act expired with no problems expressed by regulators, the companies said Wednesday....

...Arrowhead is based in Pasadena, California but its research and development are conducted in Madison and about 90 of its 110 employees are here...

   ...more

Ken Notes: So let me get this straight 90 brilliant WISCONSIN researchers generate a quarter of a billion dollars in funding so 20 suites can live Pasadena??? Arghhhhhhh!!!



- - Volume: 6 - WEEK: 45 Date: 11/8/2018 9:23:31 AM -